HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sindhu Cherian Selected Research

Sindhu Cherian Research Topics

Disease

10Neoplasms (Cancer)
01/2023 - 11/2013
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 01/2016
3Lymphoma (Lymphomas)
01/2023 - 07/2005
3Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2019 - 01/2016
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2022 - 09/2005
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2019 - 09/2017
1Leukemia
01/2024
1Plasma Cell Neoplasms
01/2023
1COVID-19
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Measles
11/2019
1Residual Neoplasm
11/2019
1Hematologic Neoplasms (Hematological Malignancy)
10/2018
1Thrombocytopenia (Thrombopenia)
11/2017
1Cytokine Release Syndrome
11/2017
1Disease Progression
09/2017
1Blast Crisis (Blast Phase)
01/2016
1Pure Red-Cell Aplasia
06/2015
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2006
1Panniculitis
10/2006
1Hyperplasia
07/2005
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2005
1Berylliosis
07/2004
1Hypersensitivity (Allergy)
07/2004

Drug/Important Bio-Agent (IBA)

7Chimeric Antigen ReceptorsIBA
12/2023 - 09/2017
6CD19-specific chimeric antigen receptorIBA
11/2019 - 01/2016
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017 - 01/2016
2fludarabineIBA
11/2017 - 01/2016
1hemoglobin P (Hb P)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1Serum AlbuminIBA
01/2021
1AntigensIBA
01/2020
1blinatumomabIBA
11/2019
1EpitopesIBA
11/2019
1Immunoglobulin G (IgG)IBA
11/2019
1Antiviral Agents (Antivirals)IBA
11/2019
1tisagenlecleucelIBA
11/2019
1Immunotoxins (Immunotoxin)IBA
10/2018
1Biomarkers (Surrogate Marker)IBA
11/2017
1ibrutinibIBA
09/2017
1Tyrosine Kinase InhibitorsIBA
01/2016
1HepcidinsIBA
06/2015
1AntibodiesIBA
11/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2006
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2006
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2006
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2006
1Rituximab (Mabthera)FDA Link
09/2005
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2005
1Immunoglobulins (Immunoglobulin)IBA
07/2005
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
07/2005
1BerylliumIBA
07/2004

Therapy/Procedure

11Therapeutics
01/2024 - 01/2016
6Drug Therapy (Chemotherapy)
01/2018 - 09/2005
5Immunotherapy
01/2023 - 01/2016
1Conservative Treatment
01/2022
1Cell Transplantation
11/2019
1Aftercare (After-Treatment)
09/2005